{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T10:47:18Z","timestamp":1783248438719,"version":"3.54.6"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:00:00Z","timestamp":1734652800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:p>Primary biliary cholangitis (PBC) with early cholestasis and extensive bile duct loss but no significant fibrosis or cirrhosis is rare and underrecognized. We aimed to clarify the clinicopathology features and prognosis of these variants of patients with early-stage PBC with ductopenia. From January 2009 to January 2023, we retrospectively collected the laboratory and pathologic data of patients with early-stage PBC and recorded their liver-related events with a median follow-up of 4.5 years. Finally, a total of 141 patients with PBC in the early stage were included and divided into 2 groups: one with ductopenia (n = 36) and the other without ductopenia (n = 105). The median age of the participants was 50 years, with 90.8% being female. The ductopenia group exhibited significantly elevated alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, gamma-glutamyl transpeptidase, total bilirubin\ufeff\ufeff, total bile acid, and total cholesterol (CHOL). Conversely, they showed a reduced biochemical response to ursodeoxycholic acid according to the Paris II, Barcelona, and Rotterdam criteria. A relatively poorer prognosis was observed in patients with early-stage PBC with ductopenia but with no statistical difference (11.8% vs 4.9%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.352). Baseline total CHOL levels were identified as an independent factor for the presence of ductopenia in early-stage PBC (odds ratio = 1.771, 95% CI: 1.264-2.479, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001). In conclusion, ductopenia was a significant risk factor for worse biochemical profiles and poor treatment response in patients with early-stage PBC. High levels of total CHOL at baseline are associated with the presence of ductopenia in early-stage PBC.<\/jats:p>","DOI":"10.1097\/pas.0000000000002343","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T12:00:35Z","timestamp":1734696035000},"page":"265-272","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Clinicopathologic Features of a Rare and Underrecognized Variant of Early-stage Primary Biliary Cholangitis With Ductopenia"],"prefix":"10.1097","volume":"49","author":[{"given":"Haitian","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Liver Research Center, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Liver Research Center, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Liver Research Center, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Liver Research Center, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Liver Research Center, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Liver Research Center, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jidong","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Liver Research Center, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8016-4368","authenticated-orcid":false,"given":"Xinyan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Liver Research Center, Beijing Friendship Hospital, Capital Medical University; National Clinical Research Center for Digestive Diseases, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,20]]},"reference":[{"key":"R1-20250219","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-021-10276-6","article-title":"APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis","volume":"16","author":"You","year":"2022","journal-title":"Hepatol Int"},{"key":"R2-20250219","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1055\/s-0041-1729972","article-title":"Drug-induced vanishing bile duct syndrome: from pathogenesis to diagnosis and therapeutics","volume":"41","author":"Bessone","year":"2021","journal-title":"Semin Liver Dis"},{"key":"R3-20250219","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1089-3261(05)70006-4","article-title":"Histopathology of chronic cholestasis and adult ductopenic syndrome","volume":"2","author":"Desmet","year":"1998","journal-title":"Clin Liver Dis"},{"key":"R4-20250219","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","article-title":"Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis","volume":"105","author":"Kumagi","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"R5-20250219","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/hepr.12423","article-title":"Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2015","journal-title":"Hepatol Res"},{"key":"R6-20250219","first-page":"529","article-title":"Clinical-pathologic relations in primary biliary cirrhosis","volume":"7","author":"Schaffner","year":"1982","journal-title":"Prog Liver Dis"},{"key":"R7-20250219","first-page":"1161","article-title":"Histopathological features predicting long-term clinical outcomes in patients with vanishing bile duct syndrome","volume":"11","author":"Lv","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"R8-20250219","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00431-018-3181-3","article-title":"Bile duct paucity in childhood\u2014spectrum, profile, and outcome","volume":"177","author":"Meena","year":"2018","journal-title":"Eur J Pediatr"},{"key":"R9-20250219","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.14309\/ajg.0000000000001985","article-title":"Longitudinal assessment of bile duct loss in primary biliary cholangitis","volume":"117","author":"Hercun","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"R10-20250219","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/gut.49.2.276","article-title":"Jaundice in non-cirrhotic primary biliary cirrhosis: the premature ductopenic variant","volume":"49","author":"Vleggaar","year":"2001","journal-title":"Gut"},{"key":"R11-20250219","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1600-0676.1988.tb01010.x","article-title":"Pathologic study of primary biliary cirrhosis of early histologic stages presenting cholestatic jaundice","volume":"8","author":"Nakanuma","year":"1988","journal-title":"Liver"},{"key":"R12-20250219","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"R13-20250219","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1440-1827.2009.02500.x","article-title":"Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement","volume":"60","author":"Nakanuma","year":"2010","journal-title":"Pathol Int"},{"key":"R14-20250219","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jhep.2011.02.031","article-title":"Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome","volume":"55","author":"Corpechot","year":"2011","journal-title":"J Hepatol"},{"key":"R15-20250219","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","article-title":"Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid","volume":"130","author":"Par\u00e9s","year":"2006","journal-title":"Gastroenterology"},{"key":"R16-20250219","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","article-title":"Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid","volume":"136","author":"Kuiper","year":"2009","journal-title":"Gastroenterology"},{"key":"R17-20250219","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2004.08.022","article-title":"Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis","volume":"41","author":"Alvaro","year":"2004","journal-title":"J Hepatol"},{"key":"R18-20250219","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/jgh.14521","article-title":"Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: a single center follow-up study from China","volume":"34","author":"Chen","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"R19-20250219","doi-asserted-by":"crossref","first-page":"E178","DOI":"10.1111\/hepr.12746","article-title":"Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis","volume":"47","author":"Namisaki","year":"2017","journal-title":"Hepatol Res"},{"key":"R20-20250219","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/jcp.34.10.1071","article-title":"Is copper hepatotoxic in primary biliary cirrhosis?","volume":"34","author":"Epstein","year":"1981","journal-title":"J Clin Pathol"},{"key":"R21-20250219","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1365-2559.2012.04278.x","article-title":"Aberrant cytokeratin 7 expression of centrilobular hepatocytes: a clinicopathological study","volume":"61","author":"Matsukuma","year":"2012","journal-title":"Histopathology"},{"key":"R22-20250219","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1186\/s12876-022-02538-w","article-title":"Aberrant cytokeratin 7 expression by hepatocytes can predict the ductopenia grade in primary biliary cholangitis","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"R23-20250219","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41586-018-0075-5","article-title":"De novo formation of the biliary system by TGF\u03b2-mediated hepatocyte transdifferentiation","volume":"557","author":"Schaub","year":"2018","journal-title":"Nature"},{"key":"R24-20250219","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/hep.1840030323","article-title":"Quantitation of hepatic granulomas and epithelioid cells in primary biliary cirrhosis","volume":"3","author":"Nakanuma","year":"1983","journal-title":"Hepatology (Baltimore, MD)"},{"key":"R25-20250219","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00432478","article-title":"The problem of histologic evaluation of primary biliary cirrhosis","volume":"379","author":"Popper","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"R26-20250219","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cld.2023.07.004","article-title":"Systemic complications of primary biliary cholangitis","volume":"28","author":"Zapata","year":"2024","journal-title":"Clin Liver Dis"},{"key":"R27-20250219","doi-asserted-by":"crossref","first-page":"102255","DOI":"10.1016\/j.clinre.2023.102255","article-title":"Xanthoma striatum palmare: getting a handle on hyperlipidaemia in primary biliary cholangitis","volume":"48","author":"Sexton","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R28-20250219","doi-asserted-by":"crossref","first-page":"621","DOI":"10.18388\/abp.2015_971","article-title":"Rapid normalization of severe hypercholesterolemia mediated by lipoprotein X after liver transplantation in a patient with cholestasis - a case report","volume":"62","author":"Jankowski","year":"2015","journal-title":"Acta Biochim Pol"},{"key":"R29-20250219","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.cgh.2024.01.039","article-title":"Hypercholesterolemia is associated with dysregulation of lipid metabolism and poor prognosis in primary biliary cholangitis","volume":"22","author":"Zheng","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R30-20250219","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hep4.1871","article-title":"High-resolution exposomics and metabolomics reveals specific associations in cholestatic liver diseases","volume":"6","author":"Walker","year":"2022","journal-title":"Hepatol Commun"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T08:00:22Z","timestamp":1739952022000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,20]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002343","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,20]]}}}